Search - tctmd.com

Displaying 941 - 960 of 3107

Sort: Relevancy | Date

Presentation Controversies and Advances 2021

Device Detected Atrial Fibrillation: NOAC or Not?

Presenter: Roopinder K. Sandhu

December 03, 2021

Presentation TCT 2021

LAAO in 2030: My 5 Top Predictions for the Field

Presenter: David Holmes Jr.

November 06, 2021

Presentation TCT 2021

Closing Complex Anatomies LAAO Devices

Presenter: Brian Whisenant

November 06, 2021

Presentation TCT 2021

Patient Anatomical Selection for LAAO: Should There Be Imaging Consensus Anatomical Criteria?

Presenter: Dee Dee Wang

November 06, 2021

Presentation TCT 2021

A Case Where I Was Really Happy to Have Pre-Procedural CT Planning as Additive Planning for Intraprocedural TEE

Presenter: Dee Dee Wang

November 06, 2021

Presentation TCT 2021

Newer Invasive Pressure Monitoring Devices

Presenter: Liviu Klein

November 06, 2021

Presentation TCT 2021

ADHF Pathophysiology and Emerging Devices (DRIIPPS)

Presenter: W. H. Wilson Tang

November 06, 2021

Presentation TCT 2021

SWISS-APERO: A Randomized Trial of the Amulet Versus Watchman FLX Devices for Left Atrial Appendage Closure

Presenter: Roberto Galea

November 06, 2021

Presentation TCT 2021

Overview of Devices for HF: Current and Future Prospects

Presenter: Marat Fudim

November 06, 2021

Presentation TCT 2021

Percutaneous Retrieval of a Malfunctioning WATCHMAN Device

Presenter: Coty Jewell

November 05, 2021

Presentation TCT 2021

First Dedicated Transcatheter Leaflet Splitting Device From Bench to FIH (ShortCut)

Presenter: Susheel Kodali

November 05, 2021

Presentation TCT 2021

Biventricular Non-Blood Contacting Cardiac Assist Device for Acute Heart Failure Syndrome (CorInnova)

Presenter: William C. Altman

November 05, 2021

Presentation TCT 2021

Special (Device/Drug) Approaches to Infarct Size Reduction

Presenter: Giovanni Luigi De Maria

November 05, 2021

Presentation TCT 2021

Digital Health Apps in Cardiovascular Device Trials, From FDA Perspective

Presenter: George Van Hare

November 05, 2021

Presentation TCT 2021

Digital Health Apps in Cardiovascular Device Trials, a Clinician's Perspective

Presenter: Mintu Turakhia

November 05, 2021

Presentation TCT 2021

Heart Failure Interventions – Defining Optimal Medical Therapy in a Device Trial, From FDA Perspective

Presenter: Meir Shinnar

November 05, 2021

Presentation TCT 2021

Heart Failure Interventions – Defining Optimal Medical Therapy in a Device Trial, From Academic Perspective

Presenter: William Abraham

November 05, 2021

Presentation TCT 2021

AMULET IDE: One-Year Device Closure From a Randomized Trial of Amulet Versus Watchman for Left Atrial Appendage Occlusion

Presenter: Dhanunjaya Lakkireddy

November 05, 2021

Presentation TCT 2021

TCT 561: A Multimodality Approach to IVC and Venous Thrombosis: So Many Devices, So Little Data

Presenter: Ashley Mohadjer

November 05, 2021

Presentation TCT 2021

Debate 1: Extraplaque Wire Entry – Device-Based Re-Entry Is the Most Reliable Answer

Presenter: Arasi Maran

November 05, 2021

Advertisement

Device Detected Atrial Fibrillation: NOAC or Not?

LAAO in 2030: My 5 Top Predictions for the Field

Closing Complex Anatomies LAAO Devices

Patient Anatomical Selection for LAAO: Should There Be Imaging Consensus Anatomical Criteria?

A Case Where I Was Really Happy to Have Pre-Procedural CT Planning as Additive Planning for Intraprocedural TEE

Newer Invasive Pressure Monitoring Devices

ADHF Pathophysiology and Emerging Devices (DRIIPPS)

SWISS-APERO: A Randomized Trial of the Amulet Versus Watchman FLX Devices for Left Atrial Appendage Closure

Overview of Devices for HF: Current and Future Prospects

Percutaneous Retrieval of a Malfunctioning WATCHMAN Device

First Dedicated Transcatheter Leaflet Splitting Device From Bench to FIH (ShortCut)

Biventricular Non-Blood Contacting Cardiac Assist Device for Acute Heart Failure Syndrome (CorInnova)

Special (Device/Drug) Approaches to Infarct Size Reduction

Digital Health Apps in Cardiovascular Device Trials, From FDA Perspective

Digital Health Apps in Cardiovascular Device Trials, a Clinician's Perspective

Heart Failure Interventions – Defining Optimal Medical Therapy in a Device Trial, From FDA Perspective

Heart Failure Interventions – Defining Optimal Medical Therapy in a Device Trial, From Academic Perspective

AMULET IDE: One-Year Device Closure From a Randomized Trial of Amulet Versus Watchman for Left Atrial Appendage Occlusion

TCT 561: A Multimodality Approach to IVC and Venous Thrombosis: So Many Devices, So Little Data

Debate 1: Extraplaque Wire Entry – Device-Based Re-Entry Is the Most Reliable Answer

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content